VT-03510

N/A

Report date: 2025/05/15 15:19:51
NME

Base Information

Drug NameVT-03510
Drug Alias NameVT-03510
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionYAP-TEAD transcription activity inhibitors
TargetsTranscriptional coactivator YAP1Transcriptional enhancer factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivace Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivace Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A